Skip to main content

Table 2 Risk class based on ROR/RS

From: Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer

Subtype

Risk Class (ROR/RS)

P

Low

Medium

High

Luminal A (n = 62)

44/51

18/10

0/1

0.149

Luminal B (n = 17)

0/10

15/6

2/1

0.000

Basal-like (n = 6)

0/1

2/2

4/3

0.565

HER2-enriched (n = 2)

0/0

2/1

0/1

1.000

Total (n = 87)

44/62

37/19

6/6

0.012

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us